Global Health

A new COVID vaccine targets the original strain and Omicron. Which countries have approved it?

Trials of the bivalent COVID jab showed an eight-fold rise in neutralizing antibodies against Omicron. Image: Unsplash/CDC

Manal Mohammed

Lecturer, University of Westminster

Share:

Our Impact
The Big Picture
Explore and monitor how Global Health is affecting economies, industries and global issues
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale

Stay up to date:

Global Health

Visualisation of the Omicron structure.
BA.1 was the first omicron subvariant, but BA.5 is now the dominant variant in the UK and globally. Image: Unsplash/JINZHOU LIN

Discover

What is the World Economic Forum doing about fighting pandemics?

Have you read?

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:

Global HealthPandemic Preparedness and ResponseVaccination

Share:

Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

6 common COVID myths busted by a virologist and a public health expert

Simon Nicholas Williams and Stephen Griffin

December 6, 2022

About Us
Events
Media
Partners & Members
Language Editions

Privacy Policy & Terms of Service

© 2022 World Economic Forum